DrugPatentWatch Database Preview
Drugs in Development Information for Reparixin
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the development status for investigational drug Reparixin?
Reparixin is an investigational drug.
There have been 8 clinical trials for Reparixin.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2012.
The most common disease conditions in clinical trials are Breast Neoplasms, Reperfusion Injury, and Ischemia. The leading clinical trial sponsors are Dompé Farmaceutici S.p.A, PRA Health Sciences, and [disabled in preview].
There are eight US patents protecting this investigational drug and one hundred and sixty-eight international patents.
Summary for Reparixin
| US Patents | 8 |
| International Patents | 168 |
| US Patent Applications | 24 |
| WIPO Patent Applications | 17 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2012-10-01) |
| Vendors | 24 |
Recent Clinical Trials for Reparixin
| Title | Sponsor | Phase |
|---|---|---|
| A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer | PRA Health Sciences | Phase 2 |
| A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer | Dompé Farmaceutici S.p.A | Phase 2 |
| Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation | Dompé Farmaceutici S.p.A | Phase 2 |
Clinical Trial Summary for Reparixin
Top disease conditions for Reparixin
Top clinical trial sponsors for Reparixin
US Patents for Reparixin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Reparixin | Start Trial | Use of (R)--ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs | Dompe Pha.r.ma S.p.A. (L'Aquila, IT) | Start Trial |
| Reparixin | Start Trial | 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them | Dompe Pha.R.Ma S.p.A. (L'Aquila, IT) | Start Trial |
| Reparixin | Start Trial | 2-arylpropionic acid derivatives and pharmaceutical compositions containing them | DompePHA.R.MA S.p.A. (L'Aquila, IT) | Start Trial |
| Reparixin | Start Trial | 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them | Start Trial | |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Reparixin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Reparixin | Austria | 304846 | 2021-02-02 | Start Trial |
| Reparixin | Australia | 2002250869 | 2021-02-02 | Start Trial |
| Reparixin | Brazil | 0206804 | 2021-02-02 | Start Trial |
| Reparixin | Brazil | PI0206804 | 2021-02-02 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
